Show simple item record

dc.contributor.authorChen, Junjie
dc.contributor.authorSilver, Daniel P.
dc.contributor.authorWalpita, Deepika
dc.contributor.authorCantor, Sharon B.
dc.contributor.authorGazdar, Adi F.
dc.contributor.authorTomlinson, Gail
dc.contributor.authorCouch, Fergus J.
dc.contributor.authorWeber, Barbara L.
dc.contributor.authorAshley, Terry
dc.contributor.authorLivingston, David M.
dc.contributor.authorScully, Ralph
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:40:01Z
dc.date.available2022-08-23T15:40:01Z
dc.date.issued1998-10-17
dc.date.submitted2008-12-10
dc.identifier.citationMol Cell. 1998 Sep;2(3):317-28.
dc.identifier.issn1097-2765 (Print)
dc.identifier.pmid9774970
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26308
dc.description.abstractBRCA1 and BRCA2 account for most cases of familial, early onset breast and/or ovarian cancer and encode products that each interact with hRAD51. Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. Like BRCA1 and RAD51, BRCA2 relocates to PCNA+ replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. Thus, BRCA1 and BRCA2 participate, together, in a pathway(s) associated with the activation of double-strand break repair and/or homologous recombination. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=9774970&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/S1097-2765(00)80276-2
dc.subjectAntibodies, Monoclonal
dc.subjectBRCA1 Protein
dc.subjectBRCA2 Protein
dc.subjectBreast Neoplasms
dc.subjectCell Line
dc.subjectCell Nucleus
dc.subjectChromosome Mapping
dc.subjectDNA Damage
dc.subjectDNA Repair
dc.subjectDNA Replication
dc.subjectDNA-Binding Proteins
dc.subjectFemale
dc.subject*Genes, BRCA1
dc.subject*Genes, Tumor Suppressor
dc.subjectHumans
dc.subjectMeiosis
dc.subjectMitosis
dc.subjectNeoplasm Proteins
dc.subjectOvarian Neoplasms
dc.subjectRad51 Recombinase
dc.subjectTranscription Factors
dc.subjectTransfection
dc.subjectTumor Cells, Cultured
dc.subjectZygote
dc.subjectCancer Biology
dc.subjectNeoplasms
dc.titleStable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
dc.typeJournal Article
dc.source.journaltitleMolecular cell
dc.source.volume2
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cancerbiology_pp/7
dc.identifier.contextkey679285
html.description.abstract<p>BRCA1 and BRCA2 account for most cases of familial, early onset breast and/or ovarian cancer and encode products that each interact with hRAD51. Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. Like BRCA1 and RAD51, BRCA2 relocates to PCNA+ replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. Thus, BRCA1 and BRCA2 participate, together, in a pathway(s) associated with the activation of double-strand break repair and/or homologous recombination. Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and/or ovarian cancer.</p>
dc.identifier.submissionpathcancerbiology_pp/7
dc.contributor.departmentDepartment of Cancer Biology
dc.source.pages317-28


This item appears in the following Collection(s)

Show simple item record